PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19657384-6	2009	Erlotinib increased tumor blood flow measured by Power Doppler ultrasound and decreased hypoxia measured by EF5 immunohistochemistry and tumor O(2) saturation measured by optical spectroscopy.	Erlotinib Hydrochloride	0-9	angiogenin, ribonuclease A family, member 3	Mus musculus	108-111